New Tool Tailors Hormone Therapy For High-risk Prostate Cancer

[Guest guest]

Using one of the largest databases of prostate cancer outcomes in the

United States, Fox Chase Cancer Center researchers have developed a

prediction tool that uses a patient's clinical information to estimate

the benefit of adding androgen deprivation therapy of various durations

to radiation therapy.Click on the below link for the full story:<http://www.sciencedaily.com/releases/2008/09/080923140635.htm>